Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Sales | 12,603,000 | 12,280,000 | 11,741,000 | 11,747,000 | 11,599,000 |
| Cost of Goods | 2,217,000 | 1,962,000 | 1,790,000 | 1,671,000 | 1,668,000 |
| Gross Profit | 10,386,000 | 10,318,000 | 9,951,000 | 10,076,000 | 9,931,000 |
| Operating Expenses | 8,618,000 | 6,700,000 | 7,227,000 | 6,062,000 | 7,257,000 |
| Operating Income | 1,768,000 | 3,618,000 | 2,724,000 | 4,014,000 | 2,674,000 |
| Other Income | -54,000 | 343,000 | 359,000 | 256,000 | 292,000 |
| Pre-tax Income | 1,714,000 | 3,961,000 | 3,083,000 | 4,270,000 | 2,966,000 |
| Income Tax | 223,000 | 717,000 | 790,000 | 262,000 | 477,000 |
| Net Income Continuous | 1,489,000 | 3,239,000 | 2,290,000 | 4,006,000 | 2,484,000 |
| Net Income Discontinuous | 7,960,000 | 123,000 | 125,000 | 105,000 | 271,000 |
| Net Income | $9,449,000 | $3,362,000 | $2,415,000 | $4,111,000 | $2,732,000 |
| EPS Basic Total Ops | 1.31 | 0.47 | 0.33 | 0.56 | 0.37 |
| EPS Basic Continuous Ops | 0.21 | 0.45 | 0.31 | 0.55 | 0.33 |
| EPS Basic Discontinuous Ops | 1.10 | 0.02 | 0.02 | 0.01 | 0.04 |
| EPS Diluted Total Ops | 1.31 | 0.46 | 0.33 | 0.56 | 0.36 |
| EPS Diluted Continuous Ops | 0.22 | 0.44 | 0.31 | 0.55 | 0.32 |
| EPS Diluted Discontinuous Ops | 1.09 | 0.02 | 0.02 | 0.01 | 0.04 |
| EBITDA(a) | $3,035,000 | $4,950,000 | $4,067,000 | $5,365,000 | $4,107,000 |